BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25421939)

  • 1. The mechanism of H171T resistance reveals the importance of Nδ-protonated His171 for the binding of allosteric inhibitor BI-D to HIV-1 integrase.
    Slaughter A; Jurado KA; Deng N; Feng L; Kessl JJ; Shkriabai N; Larue RC; Fadel HJ; Patel PA; Jena N; Fuchs JR; Poeschla E; Levy RM; Engelman A; Kvaratskhelia M
    Retrovirology; 2014 Nov; 11():100. PubMed ID: 25421939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitors.
    Feng L; Sharma A; Slaughter A; Jena N; Koh Y; Shkriabai N; Larue RC; Patel PA; Mitsuya H; Kessl JJ; Engelman A; Fuchs JR; Kvaratskhelia M
    J Biol Chem; 2013 May; 288(22):15813-20. PubMed ID: 23615903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency.
    Feng L; Dharmarajan V; Serrao E; Hoyte A; Larue RC; Slaughter A; Sharma A; Plumb MR; Kessl JJ; Fuchs JR; Bushman FD; Engelman AN; Griffin PR; Kvaratskhelia M
    ACS Chem Biol; 2016 May; 11(5):1313-21. PubMed ID: 26910179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical role of the C-terminal segment for allosteric inhibitor-induced aberrant multimerization of HIV-1 integrase.
    Shkriabai N; Dharmarajan V; Slaughter A; Kessl JJ; Larue RC; Feng L; Fuchs JR; Griffin PR; Kvaratskhelia M
    J Biol Chem; 2014 Sep; 289(38):26430-26440. PubMed ID: 25118283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain.
    Patel D; Antwi J; Koneru PC; Serrao E; Forli S; Kessl JJ; Feng L; Deng N; Levy RM; Fuchs JR; Olson AJ; Engelman AN; Bauman JD; Kvaratskhelia M; Arnold E
    J Biol Chem; 2016 Nov; 291(45):23569-23577. PubMed ID: 27645997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized binding of substituted quinoline ALLINIs within the HIV-1 integrase oligomer.
    Sun J; Patel K; Hume J; Pigza JA; Donahue MG; Kessl JJ
    J Biol Chem; 2021; 296():100363. PubMed ID: 33539919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling study on the allosteric inhibition mechanism of HIV-1 integrase by LEDGF/p75 binding site inhibitors.
    Xue W; Liu H; Yao X
    PLoS One; 2014; 9(3):e90799. PubMed ID: 24599328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric HIV-1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter-subunit interactions: Structural and thermodynamic modeling studies.
    Deng N; Hoyte A; Mansour YE; Mohamed MS; Fuchs JR; Engelman AN; Kvaratskhelia M; Levy R
    Protein Sci; 2016 Nov; 25(11):1911-1917. PubMed ID: 27503276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome.
    van Bel N; van der Velden Y; Bonnard D; Le Rouzic E; Das AT; Benarous R; Berkhout B
    PLoS One; 2014; 9(7):e103552. PubMed ID: 25072705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
    Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW
    FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation.
    Jurado KA; Wang H; Slaughter A; Feng L; Kessl JJ; Koh Y; Wang W; Ballandras-Colas A; Patel PA; Fuchs JR; Kvaratskhelia M; Engelman A
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8690-5. PubMed ID: 23610442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new class of multimerization selective inhibitors of HIV-1 integrase.
    Sharma A; Slaughter A; Jena N; Feng L; Kessl JJ; Fadel HJ; Malani N; Male F; Wu L; Poeschla E; Bushman FD; Fuchs JR; Kvaratskhelia M
    PLoS Pathog; 2014 May; 10(5):e1004171. PubMed ID: 24874515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization.
    Christ F; Shaw S; Demeulemeester J; Desimmie BA; Marchand A; Butler S; Smets W; Chaltin P; Westby M; Debyser Z; Pickford C
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4365-74. PubMed ID: 22664975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration.
    Bonnard D; Le Rouzic E; Eiler S; Amadori C; Orlov I; Bruneau JM; Brias J; Barbion J; Chevreuil F; Spehner D; Chasset S; Ledoussal B; Moreau F; Saïb A; Klaholz BP; Emiliani S; Ruff M; Zamborlini A; Benarous R
    J Biol Chem; 2018 Apr; 293(16):6172-6186. PubMed ID: 29507092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric Integrase Inhibitor Influences on HIV-1 Integration and Roles of LEDGF/p75 and HDGFL2 Host Factors.
    Singh PK; Li W; Bedwell GJ; Fadel HJ; Poeschla EM; Engelman AN
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the LEDGF/p75 binding site in HIV-1 integrase.
    Busschots K; Voet A; De Maeyer M; Rain JC; Emiliani S; Benarous R; Desender L; Debyser Z; Christ F
    J Mol Biol; 2007 Feb; 365(5):1480-92. PubMed ID: 17137594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor.
    Fenwick C; Amad M; Bailey MD; Bethell R; Bös M; Bonneau P; Cordingley M; Coulombe R; Duan J; Edwards P; Fader LD; Faucher AM; Garneau M; Jakalian A; Kawai S; Lamorte L; LaPlante S; Luo L; Mason S; Poupart MA; Rioux N; Schroeder P; Simoneau B; Tremblay S; Tsantrizos Y; Witvrouw M; Yoakim C
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3233-44. PubMed ID: 24663024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 integrase modulates the interaction of the HIV-1 cellular cofactor LEDGF/p75 with chromatin.
    Astiazaran P; Bueno MT; Morales E; Kugelman JR; Garcia-Rivera JA; Llano M
    Retrovirology; 2011 Apr; 8():27. PubMed ID: 21510906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric inhibition of HIV-1 integrase activity.
    Engelman A; Kessl JJ; Kvaratskhelia M
    Curr Opin Chem Biol; 2013 Jun; 17(3):339-45. PubMed ID: 23647983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinoline-based Protein-protein Interaction Inhibitors of LEDGF/p75 and HIV Integrase: An In Silico Study.
    Chhokar N; Kalra S; Chauhan M; Munshi A; Kumar R
    Curr Top Med Chem; 2018; 18(32):2800-2815. PubMed ID: 30747071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.